FDA Investigator Yangmin Ning

Yangmin Ning has inspections in 3 countries as of 06 Oct 2023. Yangmin Ning has collaborated with a combinined 2209 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
8
Last Inspection Date:
06 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
France, United States of America, Taiwan
Co-Investigator(s):
Amy L Singer, Ana P Barido, Anastasia I Offordile, Andrace Lde Yampert, Andrea D Swingle, Angela Shepas, Anita R Michael, Ann Marie Montemurro, Bei Y He, Bei Yu, Benjamin J Smith, Brandon L Mariner, Byungja E Marciante, Charles I Ann, Charles L Zhou, Charles R Bonapace, PhD, Constantin Y Philopoulos, Corrine M Carter, Cynthia Jim, CSO, Cynthia White, David A Paterson, David L Chon, Debara R Reese, Debara Reese, Deborah A Greco, Denise L Burosh, Dennis E Guilfoyle, PhD, Dina A Tallman, Donald C Obenhuber, PhD, Dorothy J Denes, Douglas C Kovacs, Dr. Mark J Seaton, PhD, Emest F Bizjak, Emily J Orban, Gayle S Lawson, George Pyramides, Greg K Keshishyan, Hector J Colon Torres, Humberto Z Gomez, James M Mason, Jean Blackston Hill, Jean Blackstone Hill, Jean M Mulinde, MD, Jeanne J Thai, Jeffrey A Sommers, Jeffrey D Meng, Jennifer A Kemp, Joan A Loreng, John Dan, Jonee J Mearns, Joseph A Piechocki, Joseph L Despins, PhD, Joseph R Strelnik, Julianne C Mccullough, Justine Tomasso, Karen M Cooper, Karen M Montgomery (KMM), Kristen D Evans, Kristina J Donohue, Kristina Mjoyce Pittman, Kristy A Zielny, Kurt A Brorson, PhD, L'oreal F Walker, Lakecha N Lewis, Larry K Austin, Lauren Iacono Connors, PhD, Lee Hong Pai Scherf, Leigh Anne Myers, Lisa M Bellows, Lori S Lawless, Luella J Rossi, Lynda L Lanning, Marcelo O Mangalindan, Jr, Meisha R Sampson, Meisha Waters, Melina Rodriguez Upton, Mercy Oyugi, Michael Serrano, Michael Shanks, MS, Michele L Forster, PhD, Montgomery Montgomery, Karen M, Morris Paul, Muna Algharibeh, Myra K Casey, Nailing Zhang, Neali H Lucas, Nebil A Oumer, Ni A Khin, MD, Patricia A Cochran, Patricia H Dlugosz, Patrick B Cummings, Patsy J Domingo, Peter R Lenahan, Prabhu P Raju, Qiao Y Bobo, Rafeeq A Habeeb, Raymond T Oji, Rebecca E Dombrowski, Richard W Berning, Robert D Tollefsen, Robert J Ham, Robert M Barbosa, Robin R Waller, Sandra A Boyd, Shelley H Beausoleil, Stephanie Mangigian, MS/OSH, RN, Subramanian Muthukkumar, PhD, Susan D Yuscius, Susan F Laska, MS, Susan P Bruederle, Susant Hadman, Suyang Qin, Thomas E Friel, Thomas J Arista, Thuy T Nguyen, LCDR, Tina M Pawlowski, Tyanna N Hadley, Vlada Matusovsky, Wayne E Seifert, William D Tingley, Yumi J Hiramine

Yangmin Ning's Documents

Publish Date Document Type Title
November, 2018 EIR Janssen Biotech, Inc. - EIR, 2018-11-30
May, 2019 FDA 483 Puma Biotechnology, Inc. - Form 483, 2019-05-24
September, 2019 FDA 483 Ming-Shen Dai, M.D., Ph.D. - Form 483, 2019-09-27
September, 2019 EIR Ming-Shen Dai, M.D., Ph.D. - EIR, 2023-12-05

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more